Lynda M. Brown

Lynda M. Brown serves as a Contracting Officer responsible for managing the acquisition of biological products excluding diagnostic agents, ensuring compliance with federal procurement regulations and mission-critical supply chain needs. In this role, she oversees the full lifecycle of contract actions—from market research and solicitation development to award administration and performance evaluation—supporting the agency’s objective to secure high-integrity, scientifically validated biological materials for public health and national security applications. Her acquisitions are characterized by rigorous technical evaluation, stringent regulatory alignment, and adherence to Good Manufacturing Practices (GMP) standards. While no specific contractor relationships are currently identifiable in the data, Brown consistently engages with a diverse pool of manufacturers and contract development and manufacturing organizations (CDMOs) capable of producing sterile, biologic, and pharmaceutical-grade products under FDA oversight. Her procurement approach emphasizes vendor qualifications, quality control systems, and supply chain resilience, fostering long-term partnerships with firms demonstrating technical expertise and regulatory compliance. Brown’s contracting patterns reflect a singular focus on open competition, with 100% of her acquisitions conducted without set-asides, indicating a preference for full and open competition based on technical merit and capability rather than socioeconomic classifications. This approach underscores her commitment to selecting the most qualified suppliers regardless of business size or certification status, while still ensuring equitable access for all eligible vendors. Her primary area of expertise lies in NAICS 325414—Biological Product (except Diagnostic) Manufacturing—where she procures complex biologics such as vaccines, therapeutic proteins, and cell-based therapies. She possesses deep technical familiarity with cGMP requirements, cold chain logistics, and biosafety protocols, ensuring that all contracted products meet stringent federal standards for safety, purity, and potency.